Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации

В соглашении экспертов российских сообществ обсуждаются вопросы комплексной медицинской реабилитации больных с новой коронавирусной инфекцией. Коронавирусная болезнь 2019 (COVID-19) — контагиозное инфекционное заболевание, которое может вызывать респираторные, кардиологические, двигательные, метаболические, нейрокогнитивные и психические нарушения, т.е. полиорганную дисфункцию. Больные, выжившие после COVID-19, особенно после тяжелой формы, сталкиваются с серьезными проблемами психологического и физического характера, посттравматическим стрессом, когнитивной дисфункцией, нутритивной недостаточностью и обострением сопутствующих хронических заболеваний. У части больных независимо от тяжести течения коронавирусной инфекции отмечается продолжительное течение болезни (“chronic-COVID”, “long COVID”). Появились данные о развитии “пост-COVID-19 синдрома”. В этой связи больные, перенесшие COVID-19, будут нуждаться в проведении реабилитационных мероприятий. В Консенсусе экспертов Российских сообществ представлены общие принципы, этапы и аспекты медицинской реабилитации после COVID-19, показания и противопоказания к реабилитационным вмешательствам. Консенсусный документ включает рекомендации по комплексной кардиологической и респираторной реабилитации, а также особенности реабилитационной помощи при разных вариантах клинического течения COVID-19 в рамках национальной трехэтапной системы медицинской реабилитации.

1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 48. World Health Organization. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4. (22 March 2021).

2. Brugliera L, Spina A, Castellazzi P, et al. Rehabilitation of COVID-19 patients. J Rehabil Med. 2020;52(4):jrm00046. https://doi.org/10.2340/16501977-2678.

3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. https://doi.org/10.1001/jama.2020.1585.

4. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. и др. Международный регистр “Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (AКТИВ SARS-CoV-2)”: анализ 1000 пациентов. Российский кардиологический журнал. 2020;25(11):4165. https://doi.org/10.15829/1560-4071-2020-4165.

5. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-848. https://doi.org/10.1007/s00134-020-05991-x.

6. Глыбочко П.В., Фомин В.В., Авдеев С.Н. и др. Клиническая характеристика 1007 больных тяжелой SARS-CoV-2 пневмонией, нуждавшихся в респираторной поддержке. Клин. Фармакол. Тер. 2020;29(2):21-9. https://doi.org/10.32756/0869-5490-2020-2-21-29.

7. National Institute for Health and Care Excellence, Royal College of General Practitioners, Healthcare Improvement Scotland SIGN. COVID-19 rapid guideline: managing the longterm effects of COVID-19. London: National Institute for Health and Care Excellence, 2020. https://www.nice.org.uk/guidance/ng188 (18 Dec. 2020).

8. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. https://doi.org/10.1038/s41586-020-2012-7.

9. Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARSCoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-90. https://doi.org/10.1007/s00134-020-05985-9.

10. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:1-10. https://doi.org/10.1016/j.cell.2020.02.052.

11. Самсонова М.В., Черняев А.Л., Омарова Ж.Р. и др. Особенности патологической анатомии легких при COVID-19. Пульмонология. 2020;30(5):519-32. https://doi.org/10.18093/0869-0189-2020-30-5-519-532.

12. Зайратьянц О.В., Cамсонова М.В., Михалева Л.М. и др. Патологическая анатомия легких при COVID-19: атлас. Под ред. Зайратьянца О.В. Москва; Рязань: Издательство ГУП РО “Рязанская областная типография”, 2020. с. 52, ил. 62. ISBN: 978-5-91255-313-4.

13. Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. https://doi.org/10.1016/j.rmed.2020.105941.

14. Pericá JM, Hernandez-Meneses M, Sheahan TP, et al. COVID-19: from epidemiology to treatment. European Heart Journal. 2020;41:2092-108. https://doi.org/10.1093/eurheartj/ehaa462.

15. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine. 2020;180(7):934-43. https://doi.org/10.1001/jamaimternmed.2020.1429.

16. Parohan M, Yaghoubi S, Seraji A, et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416-24. https://doi.org/10.1080/13685538.2020.1774748.

17. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. 2020. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESCCOVID-19-Guidance. (20 March 2021).

18. Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur. Heart J. 2020;41:1821-9. https://doi.org/10.1093/eurheartj/ehaa388.

19. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3.

20. Chen R, Liang W, Jiang M, et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. CHEST. 2020;158(1):97-105. https://doi.org/10.1016/j.chest.2020.04.010.

21. Hendren NS, Drazner MH, Bozkurt B, et al. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020;141:1903-14. https://doi.org/10.1161/CIRCULATIONAHA.120.047349.

22. Guzik T, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research. 2020;116(10):1666-87. https://doi.org/10.1093/cvr/cvaa106.

23. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230-2. https://doi.org/10.1007/s00059-020-04909-z.

24. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-98. https://doi.org/10.1007/s00134-020-06062-x.

25. Llitjos J, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J. Thromb Haemost. 2020;18(7):1743-6. https://doi.org/10.1111/jth.14869.

26. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. https://doi.org/10.1016/j.thromres.2020.04.013.

27. Poissy J, Goutay J, Caplan M, et al. Lille ICU Haemostasis COVID-19 group. Pulmonary Embolism in COVID-19 Patients: awareness of an increased prevalence. Circulation. 2020;142:184-6. https://doi.org/10.1161/CIRCULATIONAHA.120.047430.

28. Bansal M. Cardiovascular disease and COVID-19. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14:247-50. https://doi.org/10.1016/j.dsx.2020.03.013.

29. Hendren NS, Grodin JL, Drazner MH. Unique Patterns of Cardiovascular Involvement in COVID-19. J Card Fail. 2020;26(6):466-9. https://doi.org/10.1016/j.cardfail.2020.05.006.

30. Cooper LTJr. Myocarditis. N Engl J Med. 2009;360(15):1526-38. https://doi.org/10.1056/NEJMra0800028.

31. Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post- COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-59. https://doi.org/10.1136/bjsports-2020-102596.

32. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. https://doi.org/10.1001/jamaneurol.2020.1127.

33. Oxley T, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N. Engl. J. Med. 2020;382(20):e60. https://doi.org/10.1056/NEJMc2009787.

34. Pérez CA. Looking ahead: The risk of neurologic complications due to COVID-19. Neurology: Clinical Practice. 2020;10(4):371-4. https://doi.org/10.1212/CPJ.0000000000000836.

35. Poyiadji N, Shahin G, Noujaim D, et al. COVID 19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020;296(2):e119-e120. https://doi.org/10.1148/radiol.2020201187.

36. Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARSCoV-2. N. Engl J Med. 2020;382(26):2574-6. https://doi.org/10.1056/NEJMc2009191.

37. Talan J. COVID-19: Neurologists in Italy to colleagues in US: Look for poorly-defined neurologic conditions in patients with the coronavirus. Neurology Today, American Academy of Neurology 2020. Available from: https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=920. (20 March 2021).

38. British Geriatrics Society. COVID-19: Dementia and cognitive impairment. [accessed 11.05.2020]. https://www.bgs.org.uk/resources/covid-19-dementia-and-cognitiveimpairment. (20 March 2021).

39. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020;89:531-42. https://doi.org/10.1016/j.bbi.2020.05.048.

40. Xiang YT, Zhao YJ, Liu ZH, et al. The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform. Int J. Bio Sci. 2020;16:1741- 4. https://doi.org/10.7150/ijbs.45072.

41. Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology. 2020;158(6):1518-9. https://doi.org/10.1053/j.gastro.2020.02.054.

42. Mao R, Qiu Y, He J-S, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-78. https://doi.org/10.1016/S2468-1253(20)30126-6.

43. Chuan WJ, Vi ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Eng.J. Med. 2020;382(18):1708-20. https://doi.org/10.1056/NEJMoa2002032.

44. Временные методические рекомендации Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) версия 9 (26.10.2020) Министерства здравоохранения Российской Федерации. https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/052/550/original/МР_COVID-19_(v9).pdf?1603788097.

45. Заболотских И.Б., Киров М.Ю., Лебединский К.М. и др. Анестезиолого-реанимационное обеспечение пациентов с новой коронавирусной инфекцией COVID-19. Методические рекомендации Общероссийской общественной организации “Федерация анестезиологов и реаниматологов”. Вестник интенсивной терапии им. А.И. Салтанова. 2020;S1:3-120 https://doi.org/10.21320/1818-474X-2020-S1-9-120.

46. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-2. https://doi.org/10.1016/S2213-2600(20)30076-X.

47. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. https://doi.org/10.1016/S2213-2600(20)30079-5.

48. Vitacca M, Carone M, Clini E, et al. L’Associazione Riabilitatori dell’Insufficienza Respiratoria. 2020. Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian position paper. Respiration. 2020;99(6):493-9. https://doi.org/10.1159/000508399.

49. Thomas P, Baldwin C, Bissett B, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73‐82. https://doi.org/10.1016/j.jphys.2020.03.011.

50. Ohtake PJ, Lee AC, Scott JC, et al. Physical impairments associated with post-intensive care syndrome: systematic review based on the World Health Organization’s International Classification of Functioning, Disability and Health Framework. Phys. Ther. 2018;98(8):631- 45. https://doi.org/10.1093/ptj/pzy059.

51. Белкин А.А., Авдюнина И.А., Варако Н.А. и др. Реабилитация в интенсивной терапии. Клинические рекомендации. Вестник восстановительной медицины. 2017;2(78):139-43.

52. Herridge MS, Moss M, Hough CL, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med. 2016;42(5):725-38. https://doi.org/10.1007/s00134-016-4321-8.

53. Carda S, Invernizzi M, Bavikatte G, et al. The role of physical and rehabilitation medicine in the COVID-19 pandemic: the clinician’s view. Ann Phys Rehabil Med. 2020;63(6):554-6. https://doi.org/10.1016/j.rehab.2020.04.001.

54. Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-5. https://doi.org/10.1001/jama.2020.12603.

55. Perrin R, Riste L, Hann M, et al. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. https://doi.org/10.1016/j.mehy.2020.110055.

56. Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications. (16 Dec 2020).

57. Vaes AW, Machado FVC, Meys R, et al. Care Dependency in Non-Hospitalized Patients with COVID-19. J Clin Med. 2020;9:2946. https://doi.org/10.3390/jcm9092946.

58. Иванова Г.Е., Баландина И.Н., Батышева Т.Т. и др. Медицинская реабилитация при новой коронавирусной инфекции (COVID-19). Временные методические рекомендации МЗ РФ. Версия 2 от 31.07.2020. с.150 [Электронный ресурс]. https://www.edu.rosminzdrav.ru/fileadmin/user_upload/specialists/COVID-19/dop-materials/VMR_medreabilitacija_COVID_versija2.pdf.

59. Simpson R, Robinson L. Rehabilitation following critical illness in people with COVID-19 infection. Am J Phys Med Rehabil. 2020;99(6):470-4. https://doi.org/10.1097/PHM.0000000000001443.

60. Справочник по профилактике и лечению COVID19. Под ред. Т. Лян. Ханчжоу: Изд-во Чжэцзянского университета, 2020. с. 68.

61. Zhao H-M, Xie Y-X, Wang C. Recommendations for respiratory rehabilitation in adults with COVID-19. Chinese Association of Rehabilitation Medicine, Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine Rehabilitation. Chin Med J (Engl). 2020;133(13):1595-602. https://doi.org/10.1097/CM9.0000000000000848.

62. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-44. https://doi.org/10.1164/rccm.2107138.

63. Centers for Disease Control and Prevention. Discontinuation of Isolation for persons with COVID-19 not in healthcare settings (Interim Guidance). 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html.

64. Cheng Y-Y, Chen C-M, Huang W-C, et al. Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary Rehabilitation. Journal of the Formosan Medical Association. J Formos Med Assoc. 2021;120(1 Pt 1):83-92. https://doi.org/10.1016/j.jfma.2020.08.015.

65. Yang L-L, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Diseases and Translational Medicine. 2020;6:79-86. https://doi.org/10.1016/j.cdtm.2020.05.002.

66. Авдеев С.Н., Царева Н.А., Мержоева З.М. др. Практические рекомендации по кислородотерапии и респираторной поддержке пациентов с COVID-19 на дореанимационном этапе. Пульмонология. 2020;30(2):151- 63. https://doi.org/10.18093/0869-0189-2020-30-2-151-163.

67. Felten-Barentsz KM, van Oorsouw R, Klooster E, et al. Recommendations for hospitalbased physical therapists managing patients with COVID-19. Phys Ther. 2020;100(9):1444- 57. https://doi.org/10.1093/ptj/pzaa114.

68. Мещерякова Н.Н., Белевский А.С., Кулешов А.В. Легочная реабилитация пациентов, перенесших коронавирусную инфекцию COVID-19 (клинические примеры). Пульмонология. 2020;30(5):715-22. https://doi.org/10.18093/0869-0189-2020-30-5-715-722.

69. Edwards AM, Wells C, Butterly R. Concurreny inspiratory muscle and cardiovascular training differentially improves both perceptions of effort and 5000 m running performance compared with cardiovascular training alone. Br. J. Sports Med. 2004;42(10):523-7. https://doi.org/10.1136/bjsm.2007.045377.

70. Enright SJ, Unnithan VB, Heward C, et al. Effect of high-intensity inspiratory muscle training on lung volumes, diaphragm thickness, and exercise capacity in subjects who are healthy. Phys. Ther. 2006;86(3):345-54. https://doi.org/10.1093/ptj/86.3.345.

71. Geddes EL, O’Brien K, Reid WD, et al. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med. 2008;102:1715-29. https://doi.org/10.1016/j.rmed.2008.07.005.

72. Gosselink R, De Vos J, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011;37(2):416-25. https://doi.org/10.1183/09031936.00031810.

73. Severin R, Arena R, Lavie CJ, et al. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation. Am. J. Med. 2020;133(9):1025-32. https://doi.org/10.1016/j.amjmed.2020.04.003.

74. Zhou L, Liu HG. Early detection and disease assessment of patients with novel coronavirus pneumonia. Chinese J tuberculosis and respiratory disease. 2020;43:E003. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0003.

75. Bissett B, Gosselink R, van Haren FMP. Respiratory muscle rehabilitation in patients with prolonged mechanical ventilation: a targeted approach. Crit Care. 2020;24:103. https://doi.org/10.1186/s13054-020-2783-0.

76. Royal Dutch Society for Physiotherapy 2020. KNGF position statement: Physiotherapy recommendations in patients with COVID-19. Amersfoort, Netherlands: KNGF. https://www.kngf.nl/kennisplatform/guidelines.

77. Макарова М.Р., Лямина Н.П., Сомов Д.А. и др. Физическая реабилитация при пневмонии, ассоциированной с COVID-19. Учебно-методическое пособие. Москва, 2020. с.84. https://www.elibrary.ru/item.asp?id=43055197.

78. Attaway A, Hatipoğlu U. Management of patients with COPD during the COVID-19 pandemic. Cleve Clin J Med. 2020. https://doi.org/10.3949/ccjm.87a.ccc007.

79. Бубнова М.Г., Персиянова-Дуброва А. Л., Лямина Н.П., Аронов Д.М. Реабилитация после новой коронавирусной инфекции (COVID-19): принципы и подходы. CardioСоматика. 2020;11(4):6-14. https://doi.org/10.26442/22217185.2020.4.200570.

80. Иванова Г.Е., Шмонин А.А., Мальцева М.Н. и др. Реабилитационная помощь в период эпидемии новой коронавирусной инфекции COVID-19 на первом, втором и третьем этапах медицинской реабилитации. Физическая и реабилитационная медицина, медицинская реабилитация. 2020;2(2):98-117. https://doi.org/10.36425/rehab34148.

81. Garber CE, Blissmer B, Deschenes MR, et al. Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults: Guidance for Prescribing Exercise. American College of Sports Medicine. 2011;43(7):1334-59. https://doi.org/10.1249/MSS.0b013e318213fefb.

82. Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Prev Cardiology. Eur J Prev Cardiol. 2020;28(5):460-95. https://doi.org/10.1177/2047487320913379.

83. Spruit MA, Singh SJ, Garvey C, et al. on behalf of the ATS/ERS Task Force on Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-e64. https://doi.org/10.1164/rccm.201309-1634ST.

84. Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC). Eur Heart J. 2021;42:17-96. https://doi.org/10.1093/eurheartj/ehaa605.

85. Jones CJ, Rikli RE. Measuring functional fitness of older adults. The Journal on Active Aging. 2002;24-30.

86. Briand J, Behal H, Chenivesse C, et al. The 1-minute sit-to-stand test to detect exerciseinduced oxygen desaturation in patients with interstitial lung disease. Ther Adv Respir Dis. 2018;12:1-10. https://doi.org/10.1177/1753466618793028.

87. Bohannon RW, Wang YC, Gershon RC. Two-minute walk test performance by adults 18 to 85 years: normative values, reliability, and responsiveness. Arch Phys Med Rehabil. 2015;96(3):472-7. https://doi.org/10.1016/j.apmr.2014.10.006.

88. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/ American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-46. https://doi.org/10.1183/09031936.00150314.

89. Haas F, Sweeney G, Pierre A, et al. Validation of a 2 Minute Step Test for Assessing Functional Improvement. Open Journal of Therapy and Rehabilitation. 2017;5:71-81. https://doi.org/10.4236/ojtr.2017.52007.

90. Coquart JB, Lemaitre F, Castres I, et al. Reproducibility and sensitivity of the 6-Minute Stepper Test in patients with COPD. COPD. 2015;12(5):533-8. https://doi.org/10.3109/15412555.2014.974733.

91. Бубнова М.Г., Аронов Д.М. Обеспечение физической активности граждан, имеющих ограничения в состоянии здоровья. Методические рекомендации. Под редакцией Бойцова С.А. CardioСоматика. 2016;1:5-50.

92. Бубнова М.Г., Барбараш О.Л., Долецкий А.А. и др. Острый инфаркт миокарда с подъемом сегмента st электрокардиограммы: реабилитация и вторичная профилактика. Российский кардиологический журнал. 2015;20(1):6-52. https://doi.org/10.15829/1560-4071-2015-1-6-52.

93. Бокерия Л.А., Аронов Д.М., Бубнова М.Г. и др. Российские клинические рекомендации. Коронарное шунтирование больных ИБС: реабилитация и вторичная профилактика. CardioСоматика. 2016;7(3-4):5-71.

94. Bartlo P, Bauer N. Pulmonary rehabilitation post-acute care for Covid-19 (PACER). [accessed 11.05.2020]. Available at: https://youtu.be/XjY_7O3Qpd8.

95. Barazzoni R, Bischoff SC, Breda J, et al. Endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020;39(6):1631-8. https://doi.org/10.1016/j.clnu.2020.03.022.

96. Grechko AV, Evdokimov EA, Kotenko ON, et al. Nutritional Support for Patients with COVID-19 Coronavirus Infection. Clinical nutrition and metabolism. 2020;1(2):56-91. (In Russ.) Гречко А.В., Евдокимов Е.А., Котенко О. Н. и др. Нутритивная поддержка пациентов с коронавирусной инфекцией COVID-19. Клиническое питание и метаболизм. 2020;1(2):56-91. https://doi.org/10.36425/clinnutrit42278.

97. Gorbalenya AE. Severe acute respiratory syndromerelated coronavirus - the species and its viruses, a statement of the Coronavirus Study Group. bioRxiv 2020.02.07.937862. https://doi.org/10.1101/2020.02.07.937862.

98. Martindale R, Patel JJ, Taylor B, et al. Nutrition therapy in the patient with COVID19 disease requiring ICU care. [cited 2020 April 1]. https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_ResourcesCOVID19/Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care_Updated May 26.pdf.

99. Пасечник И.Н. Нутритивная поддержка больных коронавирусной инфекцией в критических состояниях. Анестезиология и реаниматология. 2020;3:69-74. https://doi.org/10.17116/anaesthesiology202003169.

100. Critical Care Specialist Group (CCSG) of the BDA Guidance on management of nutrition and dietetic services during the COVID-19 pandemic. Version 1.2-24/03/2020. https://www.bda.uk.com/uploads/assets/f5215258-7a34-4426-83620ba89f87c638/63decf82-db85-41d7-b5a6cbabe757a4a2/CCSG-Guidance-for-COVID-19-Formatted.pdf.

101. Приказ №330 от 5.09.2003 (с поправками от 24.11.2016) МЗ РФ “О мерах по совершенствованию лечебного питания в лечебно-профилактических учреждениях Российской Федерации”. Приказ МЗ РФ №279н от 05.05.2016 “Об утверждении порядка организации санаторно-курортного лечения”. https://www.garant.ru/products/ipo/prime/doc/71327710.

102. Wang TJ, Chau B, Lui M, et al. Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19. American Journal of Physical Medicine and Rehabilitation. 2020;99(9):769-74. https://doi.org/10.1097/PHM.0000000000001505.